Journal of Drug Delivery Science and Technology, Journal Year: 2024, Volume and Issue: 102, P. 106348 - 106348
Published: Nov. 1, 2024
Language: Английский
Journal of Drug Delivery Science and Technology, Journal Year: 2024, Volume and Issue: 102, P. 106348 - 106348
Published: Nov. 1, 2024
Language: Английский
ChemistrySelect, Journal Year: 2025, Volume and Issue: 10(4)
Published: Jan. 1, 2025
Abstract The increasing use of metal oxide nanoparticles demands a better understanding their health impact. Here, we report the synthesis copper (I) (Cu 2 O NPs) using cost‐effective chemical methods and assessed photocatalytic, antibacterial, anticancer properties. X‐ray diffraction (XRD) pattern verified its cubic structure. average crystallite size 11 nm was obtained Scherrer method. Fourier transform infrared (FTIR) spectroscopy confirmed formation Cu NPs. spherical morphology through field emission scanning electron microscopy (FESEM) analysis. High‐resolution transmission (HRTEM) estimated to be around 15 nm. photoelectron (XPS) spectra NPs showed peaks at 931.75 951.82 eV, corresponding 2p 3/2 1/2 , respectively. UV–vis revealed optical direct bandgap (2.33 eV) Under light irradiation, catalyst achieved tetracycline (TC) degradation efficiency 80% within 75 min. antibacterial properties against Klebsiella pneumoniae Bacillus subtilis agar disk diffusion have been investigated. also exhibited significant activity MCF‐7 cancer cells MTT assay, with an IC 50 value 18.88 µg/mL.
Language: Английский
Citations
0Biochimica et Biophysica Acta (BBA) - Reviews on Cancer, Journal Year: 2025, Volume and Issue: unknown, P. 189276 - 189276
Published: Feb. 1, 2025
Language: Английский
Citations
0International Journal of Scientific Research in Science Engineering and Technology, Journal Year: 2025, Volume and Issue: 12(1), P. 164 - 180
Published: Feb. 3, 2025
Breast cancer continues to rank as a predominant cause of illness and death among women globally, emphasizing the critical need for innovative effective treatment approaches. Traditional methods such chemotherapy, surgery, radiation therapy often face limitations, including toxicity, resistance, non-specific targeting. In recent years, advancements in nanotechnology have brought about transformative solutions, with nanoengineered copper emerging frontrunner. Nanoengineered copper’s unique properties- its catalytic capabilities, biocompatibility, potential surface modification- offer unprecedented opportunities revolutionize breast care. These nanoparticles not only enable precise targeting cells but also improve diagnostic accuracy through advanced imaging techniques. Furthermore, their application photothermal photodynamic therapies provides dual approach destroying while minimizing harm healthy tissues. With ability modulate tumor microenvironment act platform combination therapies, holds immense promise both early detection treatment. This article explores wide-ranging applications copper, from innovations therapeutic breakthroughs, underscoring redefine management patient outcomes.
Language: Английский
Citations
0Redox Biology, Journal Year: 2025, Volume and Issue: 81, P. 103552 - 103552
Published: Feb. 15, 2025
Language: Английский
Citations
0Hybrid Advances, Journal Year: 2025, Volume and Issue: unknown, P. 100421 - 100421
Published: Feb. 1, 2025
Language: Английский
Citations
0European Journal of Surgical Oncology, Journal Year: 2025, Volume and Issue: 51(8), P. 110026 - 110026
Published: April 15, 2025
Language: Английский
Citations
0Journal of Drug Delivery Science and Technology, Journal Year: 2024, Volume and Issue: 102, P. 106348 - 106348
Published: Nov. 1, 2024
Language: Английский
Citations
2